BRIEF-Neurocrine Biosciences appoints Matt Abernethy as CFO
November 20, 2017 at 17:50 PM EST
* Neurocrine Biosciences appoints Matt Abernethy as chief financial officer
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|